Assessing Post-operative Outcomes After Children's Sistrunk Procedure With or Without a Drain

Not Applicable

Not yet recruiting

• Conditions: Thyroglossal Duct Cysts

• Registration Number: NCT07148895
• Lead Sponsor: University of Rochester

Brief Summary

Purpose of the Study:

This study looks at how kids recover after a type of neck surgery called the Sistrunk procedure. Some kids have a small tube (called a drain) placed during surgery, and some do not. The goal is to see if using a drain makes a difference in how well they heal.

Who Is in the Study:

Children who are having surgery to remove a thyroglossal duct cyst-a common lump in the neck that some kids are born with.

Main Questions the Study Wants to Answer:

Does using a drain lower the chance of problems at the surgery site? Does using a drain change how often kids need more treatment or have to go back to the hospital?

What Will Happen:

Kids will have the Sistrunk surgery, with or without a drain. Doctors will watch how they heal and check for any problems, like infections, needing more procedures, or going back to the hospital.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2025-08-22
• Study First Submitted QC: 2025-08-22
• Study First Posted: 2025-08-29
• Status Verified: 2025-09
• Last Update Submitted: 2025-09-04
• Last Update Posted: 2025-09-08
• Study Start: 2025-10-01
• Primary Completion: 2028-12-31
• Study Completion: 2029-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 178

Inclusion Criteria

• Children aged 18 and younger
• Diagnosis of a <3cm midline neck mass, tract or sinus as determined by preoperative physical examination and imaging
• Patient scheduled for Sistrunk procedure (excision of TGDC)
• Patient assigned to the drain or no drain groups at the time of surgery.
• Sistrunk procedure performed per best practices and standardized per surgical study protocol.
• Patient admitted for overnight observation.
• Thyroglossal duct cyst confirmed on final pathology.

Exclusion Criteria

• Patients with confirmed bleeding or immunodeficiency disorders as previously documented in electronic medical record.
• Lesions greater than 3cm on preoperative ultrasound or axial imaging
• Lingually positioned lesions.
• Evidence of overt infection at the time of surgery
• Coexistent lesion excision (e.g., branchial cleft cyst excision, thyroidectomy)
• Entry into oropharynx noted during procedure.
• Revision surgery if prior formal Sistrunk performed.
• Patients in whom the surgeon deems a drain is necessary.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Occurrence of Surgical Site Infection (SSI)	30 days post-procedure	The occurrence of surgical site infection will be assessed. An SSI is defined as an infection at the surgical site requiring treatment (e.g., antibiotics, wound drainage). A single value per participant is derived as yes (infection present) or no (infection absent). A "yes" indicates an infection occurred; a "no" indicates no infection occurred.
Occurrence of Hematoma	30 days post-procedure	The occurrence of hematoma will be assessed. A hematoma is defined as a localized collection of blood at the surgical site that is clinically significant and requires management beyond observation (e.g., drainage, surgical evacuation). A single value per participant is derived as yes (hematoma present) or no (hematoma absent). A "yes" indicates a hematoma occurred; a "no" indicates no hematoma occurred.
Occurrence of Seroma	30 days post-procedure	The occurrence of seroma will be assessed. A seroma is defined as a localized collection of serous fluid at the surgical site that is clinically significant and requires intervention (e.g., aspiration or drainage). A single value per participant is derived as yes (seroma present) or no (seroma absent). A "yes" indicates a seroma occurred; a "no" indicates no seroma occurred.

Secondary Outcome Measures

Name	Time	Method
Need for Return to Operating Room (OR) or Procedural Intervention	30 days post-procedure	The need for any surgical or procedural intervention related to the Sistrunk procedure will be recorded. A single value per participant is derived as the presence (yes) or absence (no) of an intervention. A "yes" indicates the participant required a return to the OR or procedure; a "no" indicates no intervention was required.
Hospital Readmission	30 days post-procedure	Any unplanned hospital readmission lasting greater than 23 hours after initial discharge will be recorded. A single value per participant is derived as yes (readmitted) or no (not readmitted). A "yes" indicates a readmission occurred; a "no" indicates no readmission occurred.
Hospital Length of Stay	30 days post-procedure	Hospital length of stay will be measured in total number of days admitted for the index hospitalization. A single value per participant is derived by counting the number of calendar days from admission to discharge. Higher numbers indicate longer hospitalization; lower numbers indicate shorter hospitalization.
Need for Antibiotics	30 days post-procedure	Any prescription of antibiotics specifically related to wound healing will be recorded. A single value per participant is derived as yes (antibiotics prescribed) or no (not prescribed). A "yes" indicates antibiotics were required; a "no" indicates antibiotics were not required.

Trial Locations

Locations (5)

Ann & Robert H. Lurie Children's Hospital of Chicago; 🇺🇸 Chicago, Illinois, United States

Children's Hospital Los Angeles; 🇺🇸 Los Angeles, California, United States

Connecticut Children's; 🇺🇸 Hartford, Connecticut, United States

Boston Children's Hospital; 🇺🇸 Boston, Massachusetts, United States

University of Rochester Medical Center; 🇺🇸 Rochester, New York, United States